{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T03:16:37Z","timestamp":1762917397251},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1016\/j.eururo.2012.04.035","type":"journal-article","created":{"date-parts":[[2012,4,19]],"date-time":"2012-04-19T14:55:30Z","timestamp":1334847330000},"page":"159-166","source":"Crossref","is-referenced-by-count":67,"title":["Does Comorbidity Influence the Risk of Myocardial Infarction or Diabetes During Androgen-Deprivation Therapy for Prostate Cancer?"],"prefix":"10.1016","volume":"64","author":[{"given":"Nancy L.","family":"Keating","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. James","family":"O'Malley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen J.","family":"Freedland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew R.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2012.04.035_bib0005","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1093\/jnci\/95.13.981","article-title":"National practice patterns and time trends in androgen ablation for localized prostate cancer","volume":"95","author":"Cooperberg","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.eururo.2012.04.035_bib0010","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1002\/cncr.20955","article-title":"Increasing use of gonadotropin-releasing hormone agonists for the treatment of localized prostate carcinoma","volume":"103","author":"Shahinian","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.eururo.2012.04.035_bib0015","doi-asserted-by":"crossref","first-page":"4448","DOI":"10.1200\/JCO.2006.06.2497","article-title":"Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer","volume":"24","author":"Keating","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2012.04.035_bib0020","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/jnci\/djp404","article-title":"Diabetes and cardiovascular disease during androgen deprivation therapy: observational study of veterans with prostate cancer","volume":"102","author":"Keating","year":"2010","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.eururo.2012.04.035_bib0025","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1002\/cncr.22933","article-title":"Androgen deprivation therapy increases cardiovascular morbidity in men with prostate cancer","volume":"110","author":"Saigal","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.eururo.2012.04.035_bib0030","doi-asserted-by":"crossref","first-page":"194","DOI":"10.3322\/caac.20061","article-title":"Androgen-deprivation therapy in prostate cancer and cardiovascular risk: a science advisory from the American Heart Association, American Cancer Society, and American Urological Association: endorsed by the American Society for Radiation Oncology","volume":"60","author":"Levine","year":"2010","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.eururo.2012.04.035_bib0035","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1001\/jama.2009.1137","article-title":"Hormonal therapy use for prostate cancer and mortality in men with coronary artery disease-induced congestive heart failure or myocardial infarction","volume":"302","author":"Nanda","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.eururo.2012.04.035_bib0040","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1111\/j.1464-410X.2010.09273.x","article-title":"Androgen-suppression therapy for prostate cancer and the risk of death in men with a history of myocardial infarction or stroke","volume":"106","author":"Hayes","year":"2010","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2012.04.035_bib0045","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1097\/00005650-199308000-00006","article-title":"Potential for cancer related health services research using a linked Medicare-tumor registry database","volume":"31","author":"Potosky","year":"1993","journal-title":"Med Care"},{"issue":"Suppl 8","key":"10.1016\/j.eururo.2012.04.035_bib0050","article-title":"Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population","volume":"40","author":"Warren","year":"2002","journal-title":"Med Care"},{"key":"10.1016\/j.eururo.2012.04.035_bib0055","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1001\/jama.279.17.1351","article-title":"Improving the quality of care for Medicare patients with acute myocardial infarction: results from the Cooperative Cardiovascular Project","volume":"279","author":"Marciniak","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.eururo.2012.04.035_bib0060","series-title":"HEDIS 2004 technical specifications","year":"2004"},{"key":"10.1016\/j.eururo.2012.04.035_bib0065","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1111\/j.1475-6773.2004.00317.x","article-title":"Care following acute myocardial infraction in the Veterans Health Administration: a comparison with Medicare","volume":"39","author":"Landrum","year":"2004","journal-title":"Health Serv Res"},{"key":"10.1016\/j.eururo.2012.04.035_bib0070","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1111\/j.1475-6773.2003.00191.x","article-title":"Measuring the quality of diabetes care: comparison of administrative data and medical record data","volume":"38","author":"Keating","year":"2003","journal-title":"Health Serv Res"},{"key":"10.1016\/j.eururo.2012.04.035_bib0075","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1097\/01.mlr.0000135829.73795.a7","article-title":"The influence of physicians\u2019 practice management strategies and financial arrangements on quality of care among patients with diabetes","volume":"42","author":"Keating","year":"2004","journal-title":"Med Care"},{"key":"10.1016\/j.eururo.2012.04.035_bib0080","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/S0022-5347(01)62383-8","article-title":"Time to normalization of serum testosterone after 3-month luteinizing hormone-releasing hormone agonist administered in the neoadjuvant setting: implications for dosing schedule and neoadjuvant study consideration","volume":"160","author":"Oefelein","year":"1998","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2012.04.035_bib0085","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/S0090-4295(99)00061-8","article-title":"Prospective determination of the hormonal response after cessation of luteinizing hormone-releasing hormone agonist treatment in patients with prostate cancer","volume":"53","author":"Hall","year":"1999","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2012.04.035_bib0090","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/S0895-4356(00)00256-0","article-title":"Development of a comorbidity index using physician claims data","volume":"53","author":"Klabunde","year":"2000","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.eururo.2012.04.035_bib0095","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"10.1016\/j.eururo.2012.04.035_bib0100","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1056\/NEJMoa0810095","article-title":"Duration of androgen suppression in the treatment of prostate cancer","volume":"360","author":"Bolla","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eururo.2012.04.035_bib0105","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1056\/NEJM199707313370502","article-title":"Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin","volume":"337","author":"Bolla","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eururo.2012.04.035_bib0110","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1001\/jama.292.7.821","article-title":"6-month androgen suppression plus radiation therapy vs radiation therapy alone for patients with clinically localized prostate cancer: a randomized controlled trial","volume":"292","author":"D\u2019Amico","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.eururo.2012.04.035_bib0115","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1200\/JCO.1997.15.3.1013","article-title":"Phase III trial of androgen suppression using goserelin in unfavorable-prognosis carcinoma of the prostate treated with definitive radiotherapy: report of Radiation Therapy Oncology Group Protocol 85\u201331","volume":"15","author":"Pilepich","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2012.04.035_bib0120","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1200\/JCO.2007.13.9881","article-title":"Short-term neoadjuvant androgen deprivation therapy and external-beam radiotherapy for locally advanced prostate cancer: long-term results of RTOG 8610","volume":"26","author":"Roach","year":"2008","journal-title":"J Clin Oncol"},{"issue":"Suppl 2","key":"10.1016\/j.eururo.2012.04.035_bib0125","doi-asserted-by":"crossref","first-page":"S389","DOI":"10.1007\/s11606-009-0968-y","article-title":"Prostate cancer survivorship: prevention and treatment of the adverse effects of androgen deprivation therapy","volume":"24","author":"Saylor","year":"2009","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.eururo.2012.04.035_bib0130","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1513\/pats.200807-075TH","article-title":"Chronic obstructive pulmonary disease with lung cancer and\/or cardiovascular disease","volume":"5","author":"Rodriguez-Roisin","year":"2008","journal-title":"Proc Am Thorac Soc"},{"key":"10.1016\/j.eururo.2012.04.035_bib0135","unstructured":"National diabetes fact sheet. Centers for Disease Control and Prevention Web site. http:\/\/www.cdc.gov\/diabetes\/pubs\/estimates11.htm#1. Accessed August 1, 2011."},{"key":"10.1016\/j.eururo.2012.04.035_bib0140","doi-asserted-by":"crossref","first-page":"3448","DOI":"10.1200\/JCO.2010.29.1567","article-title":"Absolute and relative risk of cardiovascular disease in men with prostate cancer: results from the Population-Based PCBaSe Sweden","volume":"28","author":"Van Hemelrijck","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2012.04.035_bib0145","doi-asserted-by":"crossref","first-page":"3452","DOI":"10.1200\/JCO.2008.20.0923","article-title":"Impact of androgen deprivation therapy on cardiovascular disease and diabetes","volume":"27","author":"Alibhai","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2012.04.035_bib0150","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1001\/jama.2009.2014","article-title":"Prevalence and trends in obesity among US adults, 1999\u20132008","volume":"303","author":"Flegal","year":"2010","journal-title":"JAMA"}],"container-title":["European Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283812005015?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283812005015?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,24]],"date-time":"2018-11-24T01:20:32Z","timestamp":1543022432000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0302283812005015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S0302283812005015"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2012.04.035","relation":{},"ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]}}}